Regarding weight loss, the FDA has approved these drugs for people whose body mass index (BMI) is greater than 30 kg/m2, or they have a BMI that is greater than 27 and have a weight-related health problem, such as high blood pressure, sleep apnea, or pre-diabetes
Therapeutic Tolerability A systematic review of 39 randomized controlled trials demonstrated a class effect, with increased risk for nausea, vomiting, diarrhea, and constipation compared with placebo in individuals without diabetes
Once patients began experiencing moderate-to-severe neuropathic symptoms, alpha-lipoic acid was introduced
Weve observed remarkable results through some of our patients, with compounded Semaglutide producing about 15-20% body weight reduction in most patients, while compounded Tirzepatide shows promising outcomes for sustainable weight loss
It has its moments, but the gist would be that when its that time of the month, its angry and acne-prone